Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development
The report, on goals for biotechnology and biomanufacturing in the US, suggests areas of investment including multiomics, cell therapies, gene editing, and microbial genome sequencing.
Fujirebio, AriBio Partnering on Alzheimer's Biomarker Development
Fujirebio will gain access to clinical samples and data collected through AriBio's ongoing Phase III study for its lead anti-Alzheimer's compound AR1001.
Cota, Genomic Testing Cooperative Ink Precision Oncology Partnership
The firms will combine real-world patient outcomes and clinical information with DNA and RNA sequencing data to help researchers advance personalized treatment approaches.
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
The company is developing a nonsurgical approach to help increase testing rates and lower the time to diagnosis for endometriosis.